Understanding how different antibodies work together to fight HIV
Linking Antibody Cooperativity and Effector Cell Engagement
This study is looking at how different combinations of antibodies can help boost the immune system's ability to fight HIV, especially in areas like mucosal tissues, to help develop better vaccines for people living with the virus.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-10894660 on NIH RePORTER |
What this research studies
This research investigates how combinations of antibodies can be designed to enhance the immune response against HIV. By studying the interactions between various antibody types and immune cells, the project aims to identify effective strategies for vaccine development. The focus is on understanding how these antibody combinations can improve the recruitment of immune cells to eliminate HIV-infected cells, particularly in mucosal tissues. This work is crucial for translating findings from animal studies into potential human applications.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk of HIV infection or those living with HIV who may benefit from improved vaccine strategies.
Not a fit: Patients who are not at risk for HIV or those who have already achieved viral suppression may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective HIV vaccines that provide better protection against the virus.
How similar studies have performed: Previous studies have shown promise in using polyclonal antibody responses in non-human primates, indicating potential for success in human applications.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Ferrari, Guido — Duke University
- Study coordinator: Ferrari, Guido
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.